Skip to main content
. 2002 May 4;324(7345):1072. doi: 10.1136/bmj.324.7345.1072

Table 5.

 Quality of life measures at end of study. Values are means (SDs) unless stated otherwise

Nurse group (n=696) Control group (n=558) Difference (95% CI) (nurse v control) P value
Global health* 4.79 (1.50) 5.02 (1.38) −0.23 (−0.40 to −0.06)  0.008
Euroqol tariff 0.37 (0.35) 0.39 (0.35) −0.02 (−0.06 to 0.02) 0.30
Parkinson's disease questionnaire*:
 Mobility 61.1 (31.9) 59.8 (32.9) 1.38 (−2.57 to 5.34) 0.49
 Activities of daily living 52.4 (28.6) 51.7 (29.9) 0.71 (−2.73 to 4.14) 0.69
 Emotional wellbeing 34.7 (24.7) 34.5 (25.8) 0.21 (−2.79 to 3.20) 0.89
 Stigma 30.6 (27.5) 30.8 (28.7) −0.14 (−3.44 to 3.16) 0.93
 Social support 15.9 (22.1) 13.7 (20.8) 2.21 (−0.66 to 5.08) 0.13
 Cognition 39.3 (23.2) 38.0 (24.4) 1.30 (−1.52 to 4.11) 0.37
 Communication 28.6 (24.4) 28.7 (25.1) −0.10 (−3.02 to 2.82) 0.95
 Bodily discomfort 45.4 (24.8) 43.7 (25.3) 1.68 (−1.26 to 4.62) 0.26
 PDQ-39 summary index 39.7 (21.2) 39.2 (22.1) 0.47 (−2.72 to 3.66) 0.77
*

High score bad. 

High score good.